Citigroup
SBBP

Citigroup’s Strongbridge Biopharma plc. SBBP Stock Holding History

Citigroup’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,914
Closed -$8K – 6568
2021
Q1 		$8K Sell
2,914
-5,186
-64% -$15.6K ﹤0.01% 5787
2020
Q4 		$20K Buy
8,100
+6,393
+375% +$15.4K ﹤0.01% 6666
2020
Q3 		$4K Sell
1,707
-3,333
-66% -$11.2K ﹤0.01% 7179
2020
Q2 		$19K Sell
5,040
-5,289
-51% -$15.8K ﹤0.01% 6673
2020
Q1 		$20K Buy
10,329
+3,062
+42% +$7.96K ﹤0.01% 6710
2019
Q4 		$15K Buy
7,267
+4,934
+211% +$9.46K ﹤0.01% 7068
2019
Q3 		$5K Sell
2,333
-8,168
-78% -$21.9K ﹤0.01% 7366
2019
Q2 		$33K Buy
10,501
+9,676
+1,173% +$35.5K ﹤0.01% 6803
2019
Q1 		$4K Buy
+825
New +$4.06K ﹤0.01% 7463
2018
Q3 		– Sell
-30,502
Closed -$183K – 7925
2018
Q2 		$183K Buy
30,502
+26,809
+726% +$196K ﹤0.01% 5161
2018
Q1 		$32K Buy
3,693
+1,889
+105% +$14.1K ﹤0.01% 6474
2017
Q4 		$14K Buy
1,804
+1,736
+2,553% +$10.8K ﹤0.01% 6907
2017
Q3 		$0 Sell
68
-47,173
-100% -$326K ﹤0.01% 7535
2017
Q2 		$338K Buy
+47,241
New +$218K ﹤0.01% 4353
2016
Q2 		– Sell
-5
Closed – – 7586
2016
Q1 		$0 Buy
+5
New +$23 ﹤0.01% 7900

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citigroup's SBBP Position: Q2 2021 in Review

Citigroup sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 2,914 shares — an estimated $8K sold.

Citigroup first reported a position in SBBP in Q1 2016 and held it in 15 quarters. The position peaked at $338K in Q2 2017. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Citigroup reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Citigroup sold 2,914 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $8K.
  • Citigroup first reported a position in Strongbridge Biopharma plc. in Q1 2016 and held it in 15 quarters.
  • Citigroup's Strongbridge Biopharma plc. position peaked at $338K in Q2 2017.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.